← Return to FDA approves Rinvoq (Upadacitinib) for GCA
DiscussionFDA approves Rinvoq (Upadacitinib) for GCA
Polymyalgia Rheumatica (PMR) | Last Active: Oct 3, 2025 | Replies (16)Comment receiving replies
Replies to "I'm with you. The side effects of Rinvoq concern me. It has the same risks as..."
Connect

And for the same reason you have stated about gastric perforations, seems pretty risky for Crohn's patients.
If Humira is working for you and you have had problems with other medications and your insurance drops Humira from their formulary, that's a problem.